WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | FDA gives expedited approval to new groundbreaking pancreatic cancer drug | 0 | 6.49 | 26-08-2026 |
| 2 | FDA approves groundbreaking new pancreatic cancer drug | 0 | 7.77 | 26-08-2026 |
| 3 | Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival | 0 | 7.13 | 04-06-2026 |
| 4 | New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer | 5 | 7 | 02-07-2026 |
| 5 | New targeted therapy shows promising early results in advanced pancreatic cancer | 2 | 7 | 05-07-2026 |
| 6 | Phoenix doctor testing new pancreatic cancer drug shown to potentially double patient survival rates | 0 | 5.82 | 29-04-2026 |
| 7 | Doctors just found a way to slow one of the deadliest prostate cancers | 7 | 8 | 22-10-2025 |
| 8 | Landmark NHS approval of cancer drugs offers new hope for children and adults with rare blood cancers | 0 | 11.77 | 17-07-2026 |
| 9 | Blood test finds hidden pancreatic cancer after treatment | 5 | 8 | 30-06-2026 |
| 10 | New antibody drug stops aggressive prostate cancer from spreading | 0 | 6.72 | 21-07-2026 |